Lindbrook Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-69
| Closed | -$22.7K | – | 2797 |
|
|
2024
Q4 | $22.7K | Sell |
69
-5
| -7% | -$1.64K | ﹤0.01% | 1212 |
|
|
2024
Q3 | $24.8K | Buy |
74
+28
| +61% | +$9.37K | ﹤0.01% | 1175 |
|
|
2024
Q2 | $12.6K | Sell |
46
-13
| -22% | -$3.55K | ﹤0.01% | 1505 |
|
|
2024
Q1 | $20.4K | Buy |
59
+4
| +7% | +$1.38K | ﹤0.01% | 1198 |
|
|
2023
Q4 | $17.8K | Buy |
55
+39
| +244% | +$12.6K | ﹤0.01% | 1243 |
|
|
2023
Q3 | $5.74K | Buy |
16
+2
| +14% | +$717 | ﹤0.01% | 1703 |
|
|
2023
Q2 | $5.31K | Sell |
14
-20
| -59% | -$7.58K | ﹤0.01% | 1771 |
|
|
2023
Q1 | $16.3K | Buy |
34
+11
| +48% | +$5.27K | ﹤0.01% | 1176 |
|
|
2022
Q4 | $9.67K | Buy |
23
+10
| +77% | +$4.21K | ﹤0.01% | 1450 |
|
|
2022
Q3 | $5K | Sell |
13
-4
| -24% | -$1.54K | ﹤0.01% | 1641 |
|
|
2022
Q2 | $8K | Sell |
17
-2
| -11% | -$941 | ﹤0.01% | 1336 |
|
|
2022
Q1 | $11K | Buy |
19
+2
| +12% | +$1.16K | ﹤0.01% | 1238 |
|
|
2021
Q4 | $13K | Sell |
17
-2
| -11% | -$1.53K | ﹤0.01% | 1157 |
|
|
2021
Q3 | $14K | Buy |
19
+1
| +6% | +$737 | ﹤0.01% | 858 |
|
|
2021
Q2 | $12K | Hold |
18
| – | – | ﹤0.01% | 971 |
|
|
2021
Q1 | $10K | Buy |
18
+2
| +13% | +$1.11K | ﹤0.01% | 1006 |
|
|
2020
Q4 | $9K | Hold |
16
| – | – | ﹤0.01% | 934 |
|
|
2020
Q3 | $8K | Buy |
16
+1
| +7% | +$500 | ﹤0.01% | 900 |
|
|
2020
Q2 | $7K | Hold |
15
| – | – | ﹤0.01% | 948 |
|
|
2020
Q1 | $5K | Buy |
15
+2
| +15% | +$667 | ﹤0.01% | 968 |
|
|
2019
Q4 | $5K | Buy |
13
+6
| +86% | +$2.31K | ﹤0.01% | 1092 |
|
|
2019
Q3 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 1236 |
|